FILTER
FILTERED INTERVIEW RESULTS
Louis P. Kassa III
PRESIDENT AND CEO, PENNSYLVANIA BIOTECHNOLOGY CENTER (PABC)
"We want scientists to focus on science, and we offer them the equipment and services so they can do that."
Debbie Hart
PRESIDENT, BIONJ
"We used our voice to educate on the value of medical innovation and boasted the strength of New Jersey’s vibrant ecosystem, which was responsible for more than 50% of all novel FDA approvals in 2023."
Ajay Tandon
CEO, VEEDA CLINICAL RESEARCH LIMITED
"Although the US may have been ahead in technology adoption initially, India has been catching up rapidly."
Donna LaVoie
PRESIDENT AND CEO, LAVOIE HEALTH SCIENCE
"There is an insatiable demand for capital and there is too much innovation to fund."
Arda Ural
PARTNER & AMERICAS INDUSTRY MARKET LEADER, HEALTH SCIENCES AND WELLNESS, EY
"The biotech sector has room to grow. Oncology, blood disorders, immunology, inflammation, rare diseases, and neurology are key therapeutic areas attracting capital and fostering innovation."
Gil Roth
PRESIDENT, PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION (PBOA)
"There are signs of funding returning in the first half of this year, potentially revitalizing early-stage projects, and benefiting the CDMO sector."
Hernan Bazan
CEO AND CO-FOUNDER, SOUTH RAMPART PHARMA
“The best way to attract investment is with serious science and well-validated clinical mechanisms of action. An asset in the clinic with a well-described mechanism of action for how it works and peer-reviewed science, including NIH funding, helps with the validity.”
Steve Tallant
SENIOR DIRECTOR, SOLUTION MARKETING GROUP AT SYSTECH, A SOLUTIONS DIVISION OF MARKEM-IMAJE
"We are taking a physical supply chain and creating a digital twin of products and data moving through the chain."
Tim Tyson
CHAIRMAN AND CEO, TRIRX PHARMACEUTICAL SERVICES
"Our focus on capacity utilization, market demand, and strategic acquisitions will be key drivers of TriRx's growth in the coming year."
Trevor Caswell
CHAIRMAN, PHARMA.AERO
"Pharma.Aero is a unique collaborative platform connecting life sciences shippers and service providers to achieve reliable end-to-end air transport for pharmaceutical cargo."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
